ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.511,91
-0,91%
S&P 500
5.270,47
-0,69%
US Dollar vs BRL
5,1548
0,04%
Bitcoin
67.085,44
-2,92%
Brent Oil
81,195
-0,41%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ENDRA Life Sciences Inc (NDRA)

  7. ENDRA Life Sciences Inc (NDRA) Notícias

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NDRA
DataHoraFonteTítuloCódigoCompanhia
20/05/202409:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
20/05/202409:00Business WireENDRA Provides Update Following In-person Meeting with FDANASDAQ:NDRAENDRA Life Sciences Inc
14/05/202417:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
14/05/202417:05Business WireENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
10/05/202418:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NDRAENDRA Life Sciences Inc
07/05/202409:00Business WireENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:NDRAENDRA Life Sciences Inc
02/05/202409:00Business WireENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International PatentsNASDAQ:NDRAENDRA Life Sciences Inc
28/03/202417:05Business WireENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
21/03/202409:00Business WireENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024NASDAQ:NDRAENDRA Life Sciences Inc
27/02/202410:00Business WireENDRA Life Sciences Installs First TAEUS System in the UKNASDAQ:NDRAENDRA Life Sciences Inc
23/02/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NDRAENDRA Life Sciences Inc
21/02/202410:00Business WireNew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS SystemNASDAQ:NDRAENDRA Life Sciences Inc
14/02/202410:30Business WireENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and EuropeNASDAQ:NDRAENDRA Life Sciences Inc
29/12/202319:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NDRAENDRA Life Sciences Inc
29/11/202310:00Business WireENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System TechnologyNASDAQ:NDRAENDRA Life Sciences Inc
27/11/202310:00Business WireENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor ConferenceNASDAQ:NDRAENDRA Life Sciences Inc
14/11/202318:05Business WireENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
08/11/202310:00Business WireENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New PatentsNASDAQ:NDRAENDRA Life Sciences Inc
07/11/202318:05Business WireENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023NASDAQ:NDRAENDRA Life Sciences Inc
06/11/202310:00Business WireENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023NASDAQ:NDRAENDRA Life Sciences Inc
07/09/202309:00Business WireAbstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023NASDAQ:NDRAENDRA Life Sciences Inc
30/08/202309:00Business WireENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDANASDAQ:NDRAENDRA Life Sciences Inc
23/08/202309:00Business WireENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European PatentsNASDAQ:NDRAENDRA Life Sciences Inc
14/08/202317:53Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NDRAENDRA Life Sciences Inc
14/08/202317:05Business WireENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
14/08/202314:30Business WireENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDANASDAQ:NDRAENDRA Life Sciences Inc
01/08/202309:00Business WireENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023NASDAQ:NDRAENDRA Life Sciences Inc
25/07/202317:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NDRAENDRA Life Sciences Inc
06/07/202317:45Business WireENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023NASDAQ:NDRAENDRA Life Sciences Inc
07/06/202309:00Business WireStudy Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023NASDAQ:NDRAENDRA Life Sciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NDRA

Seu Histórico Recente

TG
D7A
Aptiv
BIT
NSCIT0514496
Acque Veronesi
NYSE
DLR.PRFCL
Digital Realty Trust, Inc.
COIN
AUTOOGBP
ASX
VIE
Viento
LSE
RH72
Mitsu Hc Cap.24
NYSE
FRCPD
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados